Table 1.
Health Benefit | Form/Specie | Dose Used | Model | Main Effects | Reference |
---|---|---|---|---|---|
Cardiovascular | EVOO included in a Mediterranean Diet | 10 or 20 g/day | In Vivo: humans (25 subjects; 36 years old) | Prevented the production of ROS in the post-prandial period | [30] |
Anti-diabetic and cardiovascular | EVOO included in a Mediterranean Diet | 10 g/day | In Vivo: humans (25 subjects) | Reduction of blood glucose, LDL cholesterol and its oxidized form, and improved insulin level in comparison with the use of corn oil | [31] |
Cardiovascular | EVOO included in a Mediterranean Diet | 14.8 mL/day | In Vivo: humans (137 subjects; >64 years old) | Lower systolic blood pressure and improved endothelial function | [32] |
Anti-diabetic and cardiovascular | Oleuropein in a basal diet | 20 mg/day | In Vivo: humans (20 subjects; 33 years old) | Reduces glucose and oxidative markers while increases insulin blood levels | [33] |
Anti-sclerosis | EVOO and HXT in a basal diet | 20 mg/kg/day | In Vivo: rats (25 subjects) | Reduces oxidation of lipids and proteins while increases levels of glutathione peroxidase. | [34]) |
Anti-diabetic benefit and Hepatic protection | HXT in a basal diet | 20 mg/kg/day | In Vivo: mice (10 subjects) | Prevention of hepatic steatosis | [35] |
Cardiovascular | HXT in a high-fat diet | 5 mg/kg/day | In Vivo: mice (28 subjects) | Reduce cardiovascular risk by reduction of oxidative stress and increase of plasma antioxidant profile | [36] |
Cardiovascular and anti-tumor | EVOO (89.4 HXT) | 30 mL | In Vitro: breast cancer cell lines (MCF-7 and MDA-MB-231) In Vivo: rats (22 subjects) |
Decrease the oxidation of LDL cholesterol. Improve of the endothelial function, which reduced the size of the tumour | [37] |
Anti-bacterial and anti-fungal | HXT | 100–500 mM | In Vitro: Standard fungal strains: A. nidulans, A. fumigatus, A. flavus, F. oxysporum and C. albicans. Standard bacterial strains: P. aeruginosa, E. coli, Klebsiella sp., P. fluorescens, S. aureus, and B. subtilis. | Strong antifungal activity in studied fungal strains. High efficiency in fungal plasma membrane destruction. | [38] |
Cardiovascular and anti-diabetic | HXT | 9.7 mg/day | In Vitro: hepatic cell lines (HepG2) | Improvement pancreatic β-cell responsiveness which produces an increase in insulin sensitivity | [39] |
Cardiovascular | Tyrosol | 25 mg/day | In Vivo: humans (33 subjects) | Improved endothelial function, increased HDL cholesterol and antithrombin IIII, while decreased plasma homocysteine, and gene expression in peripheral blood mononuclear cells. | [40,41] |
Neuro-protector | HXT | 5 mg/kg/day | In Vivo: rats (8 subjects) | Brain accumulation of HXT produced the reduction of the oxidative stress at neuronal level, which suggested its neuroprotective activity | [42] |
Anti-inflammatory and anti-tumour | HXT | 100 µg/day | In Vivo: rats (8 subjects) | Oleuropein acts as pro-inflammatory status, whereas HXT promotes an anti-inflammatory status. | [43] |
Digestive | HXT | 150 ppm | In Vitro: CACO-2 cell lines | Increase bioavailability of Fe and Zn | [13] |
EVOO: extra virgin olive oil; ROS: reactive oxygen substance.